We previously reported a high-frequency amplification of pyrimidine metabolic pathway-related genes in ESCC tissues,2 and ribonucleotide reductase subunit M1 (RRM1) was one of many abnormal genes. This evidence concerns the gene RRM1 and esophageal squamous cell carcinoma.